OPTOMED.HEOPTOMED.HEHEL
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank30
3Y CAGR+3.4%
5Y CAGR-11.0%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+3.4%/yr
vs -6.9%/yr prior
5Y CAGR
-11.0%/yr
Recent acceleration
Acceleration
+10.3pp
Accelerating
Percentile
P30
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20254.00-25.2%
20245.34+31.1%
20234.08+12.7%
20223.62-59.6%
20218.97+25.6%
20207.14+119.0%
20193.26-32.4%
20184.82-49.2%
20179.50+0.3%
20169.47-